Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

ACG Metals appoints general manager for Gediktepe Mine

(Sharecast News) - ACG Metals announced the appointment of Barış Baş as general manager of the Gediktepe Mine in Turkey on Friday, effective immediately. The company said that, with 15 years of experience in mining operations, project management, and technical services, Baş had played a key role at Gediktepe for over eight years, most recently as mine manager.

His promotion aligned with ACG's strategy to develop internal talent and enhance local leadership, the board said.

In his new role, Baş would co-lead the execution of the Gediktepe Sulphide Expansion Project alongside technical project director Graeme Rapley, who was appointed in October.

The firm said the expansion would transition the mine's production from gold and silver to copper and zinc concentrate, with gold and silver as by-products.

It was expected to produce between 20,000 and 25,000 tonnes of copper equivalent annually over an initial 11-year mine life, with first production targeted for early 2026.

"We are delighted to promote Barış to general manager of the Gediktepe Mine, fulfilling our strategy to develop our internal talent pool," said chairman and chief executive officer Artem Volynets.

"His expertise and long-standing contributions to the mine position him well to lead the Gediktepe operating team as ACG looks to become the leading copper mining company on the LSE."

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.